Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × pidilizumab × Clear all

NCT00532259 2014-09-12

CT-011 MAb in DLBCL Patients Following ASCT

Phase 2 Completed

72 enrolled 9 charts

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse